-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines Senior Advisor to CEO Stephen Michael Kelsey Reports Sale of $4.56 Million in Common Shares

PUBT·11/18/2026 23:24:13
Listen to the news
Revolution Medicines Senior Advisor to CEO Stephen Michael Kelsey Reports Sale of $4.56 Million in Common Shares
  • Revolution Medicines' Stephen Michael Kelsey, senior advisor to the chief executive officer, sold 27,160 common shares on Nov. 16, 2026.
  • Reported sale prices ranged from $166.7506 to $171.65 per share.
  • He also exercised stock options for 27,160 common shares at $18.56 per share.
  • His directly owned common stock totaled 286,307 shares following the transactions; remaining stock options covered 108,640 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-467372), on November 18, 2026, and is solely responsible for the information contained therein.